VGM Government Relations Along with Leitten Consulting Release the Latest Update to Competitive Bidding Study

Published in Government Relations on July 15, 2022

Graphic

VGM Government, in conjunction with Brian Leitten and Leitten Consulting, has released an updated study analyzing the efforts by the Centers for Medicare and Medicaid Services (CMS) to control distribution of Durable Medical Equipment (DME). The study, “Competitive Bidding – Pressure Sore, Urological and Diabetes Equipment & Supplies. The Expanded Case for Medicare Investment in DME in 2022,” builds off the 2021 study by expanding the range of DME and adding three additional categories: equipment and supplies to prevent pressure sores, catheters and related urological supplies to resolve urine and retention and incontinence, and diabetic test strips and meter to monitor blood glucose levels.  

“As CMS forced prices down and treatment costs continued to rise, the power of a dollar spent on preventive DME became ever more powerful,” stated Brian Leitten, head of Leitten Consulting. “CMS continues to spend its budget dollars on treating the very illnesses and injuries that could be avoided if they would just invest in providing the right DME to beneficiaries before they need it.”

The previous studies were focused around three areas of DME, mobility equipment (e.g., wheelchairs, walkers, and power chairs) to avoid falls; oxygen therapy equipment to counter symptoms of COPD; and continuous positive airway pressure equipment to treat obstructive sleep apnea (OSA). In the most recent study, DME was expanded to include three new categories of Medicare Spending that are significant to Medicare beneficiaries. Adding the three new categories significantly increases the cost and potential amount that could be saved if CMS were to invest in DME. 

“With the success of the previous studies, that had shown how much could be saved if CMS invested in three main DME categories, we wanted to expand with this most recent study to encompass three additional categories and how they could be affected,” says John Gallagher, vice president, VGM Government Relations. “In turn, we hope that these studies can then be used to help educate key legislators on why it is so important, and cost efficient, to invest now into DME.” 

READ FULL STUDY

From Our Experts

Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those... VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports thumbnail VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. Senate Backs DME Relief Act with Bipartisan Support thumbnail Senate Backs DME Relief Act with Bipartisan Support In a significant development for the durable medical equipment (DME) industry and Medicare beneficiaries, the U.S. Senate has introduced S.2951, the companion legislation to H.R. 2005, known as the DMEPOS Relief Act of 2025. The Senate bill is being led by Senator James Lankford (R-OK) and has gained bipartisan support with Senator Maggie Hassan (D-NH) joining as a co-sponsor. Gov't Shutdown: What It Means for Providers thumbnail Gov't Shutdown: What It Means for Providers As expected, Democrats and Republican members of the Senate was unable to agree on terms in passing a continuing resolution (CR) ahead of the October 1st deadline, resulting in a government shutdown. But how did we get here? Oppose DMEPOS Bidding Expansion – Take Action Now thumbnail Oppose DMEPOS Bidding Expansion – Take Action Now A critical Congressional Sign-On Letter is now circulating in the House of Representatives, led by Reps. Neal Dunn (R-FL) and Greg Murphy (R-NC). This bipartisan letter calls on CMS to stop the proposed expansion of the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Competitive Bidding Program to include ostomy and urological supplies. Gov't Shutdown & Telehealth Flexibility Expiration thumbnail Gov't Shutdown & Telehealth Flexibility Expiration September 30 represents an important date for HME providers for two reasons: 1) The potential of a government shutdown and how that affects HHS and CMS, and 2) the expiration of Telehealth Flexibilities unless a Continuing Resolution (CR) is agreed upon in time.